Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • schizophrenia

    Tag: schizophrenia

    You Searched For "schizophrenia"
    AstraZeneca sells European rights for schizophrenia drug Seroquel, Seroquel XR for USD 178 million

    AstraZeneca sells European rights for schizophrenia drug Seroquel, Seroquel XR for USD 178 million

    Farhat Nasim30 Oct 2019 11:55 AM GMT
    The treatment, Seroquel, and another version, Seroquel XR, have lost patent protection in Europe and Russia, AstraZeneca said. The drug variants are pr...
    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Medical Dialogues Bureau25 Oct 2019 6:02 AM GMT
    Haloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome, Cadila Healthcare...
    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Garima29 March 2019 4:10 AM GMT
    The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative d...
    Suven Life Sciences secures Product Patents in Australia and Singapore

    Suven Life Sciences secures Product Patents in Australia and Singapore

    Farhat Nasim18 Jan 2019 4:00 AM GMT
    'We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that is being developed for cognitive disorders ...
    Lupin gets USFDA nod for generic schizophrenia drug

    Lupin gets USFDA nod for generic schizophrenia drug

    Medical Dialogues Bureau8 Jan 2019 6:40 AM GMT
    New Delhi: Drug maker Lupin Monday said it has received approval from the US health regulator to market Lurasidone Hydrochloride tablets, used in the...
    Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

    Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

    Farhat Nasim7 Jan 2019 4:15 AM GMT
    Lupin's Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg is the generic version of Sunovion Pharmaceuticals, Inc's Latuda Tabl...
    USFDA accepts application for Indivior

    USFDA accepts application for Indivior's new schizophrenia drug

    Ruby Khatun Khatun15 Dec 2017 4:15 AM GMT
    U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday,...
    Zydus gets USFDA nod for schizophrenia drug

    Zydus gets USFDA nod for schizophrenia drug

    Ruby Khatun Khatun11 Dec 2017 5:30 AM GMT
    New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment ...
    Suven Life Sciences gets patents from India, US, Hong Kong on neurological molecule

    Suven Life Sciences gets patents from India, US, Hong Kong on neurological molecule

    Ruby Khatun Khatun17 Nov 2017 4:30 AM GMT
    New Delhi: Suven Life Sciences said it has been granted a patent each from Hong Kong and the US and two from India for treatment of disorders...
    FDA approves first drug in US with digital ingestion tracking

    FDA approves first drug in US with digital ingestion tracking

    Ruby Khatun Khatun15 Nov 2017 5:15 AM GMT
    The U.S. Food and Drug Administration (FDA) approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole ...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 27 May 2022 6:45 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X